is semaglutide anti-inflammatory Microdosing Semaglutide: Chart, Dose & Schedule (2026) Type 2 diabetes: New Ozempic

Second class: vildagliptin, saxagliptin (more active than vildagliptin)

Wegovy (semaglutide 2.4 mg) approved in the US for the treatment of MASH Novo Nordisk Novo Nordisk announced that the FDA has approved an additional indication for Wegovy (semaglutide 2.4 mg) based on a supplemental New Drug Application (sNDA) for treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis), in combination with a reduced calorie diet and increased physical activity

Avoid touching the needle or vial opening to minimize contamination

The responder rates are more decision-useful than the mean: Tirzepatide roughly doubled the odds of hitting the 25% threshold and nearly tripled them at 30%